Epidemiology Of Drug Abuse (R21) | Apply Online

Opportunity Summary:

The Epidemiology of Drug Abuse (R21) opportunity (Funding Opportunity Number PA-08-125) is a National Institutes of Health (NIH) discretionary grant program designed to support exploratory and developmental studies in drug abuse epidemiology. Its core aim is to broaden and strengthen epidemiologic research that explains the nature and scope of drug abuse, the harms and downstream consequences associated with it, and the underlying causes and pathways that lead to abuse. The announcement emphasizes work that can illuminate how drug abuse develops and operates across different layers of human life, including individuals, families, age groups, gender, communities, and broader population subgroups. In practice, this points to research that can describe patterns and trends, identify risk and protective factors, clarify causal mechanisms, and improve understanding of who is affected, how, and why, with attention to variation across demographic and social contexts.

This program uses the NIH R21 mechanism, which is intended for early-stage, exploratory, or proof-of-concept projects where investigators may be testing new ideas, piloting innovative methods, or generating preliminary data that could support a larger future study. The FOA notes that it runs in parallel with two related announcements that share the same scientific scope but use different award mechanisms: PA-08-124 for the R01 mechanism (generally used for more mature, full-scale research projects) and PA-08-126 for the R03 mechanism (typically smaller, short-term projects). In other words, the topic area is consistent across the three announcements, but PA-08-125 specifically targets the kind of developmental work suited to an R21.

Funding under PA-08-125 is not guaranteed; awards depend on the availability of NIH funds and on whether a sufficient number of high-quality, competitive applications are submitted. The opportunity lists an award ceiling of $200,000, reflecting the upper bound of support anticipated for projects under this announcement. There is no cost sharing or matching requirement, which means applicants are not required to commit non-federal funds as a condition of receiving an award.

Eligibility is broad and includes a wide range of organizations and government entities. Eligible applicants include public and private institutions of higher education, nonprofits (including both 501(c)(3) and certain nonprofits without 501(c)(3) status), for-profit organizations (including small businesses and other for-profits), and multiple levels of government such as state, county, city/township, special district governments, and eligible federal agencies. The eligibility language also explicitly includes a variety of mission-focused and community-rooted institutions and organizations, such as Historically Black Colleges and Universities (HBCUs), Hispanic Serving Institutions, Tribally Controlled Colleges and Universities (TCCUs), Alaska Native and Native Hawaiian Serving Institutions, faith-based or community-based organizations, and tribal governments (both federally recognized and other than federally recognized). The announcement further indicates that non-U.S. entities (foreign organizations), regional organizations, and U.S. territory or possession agencies may be eligible, highlighting NIH’s openness to a diverse applicant pool when the proposed work fits the epidemiology of drug abuse focus.

Key administrative details in the source data place this opportunity within the NIH grant system and the federal drug abuse research portfolio. The CFDA number associated with the program is 93.279 (Drug Abuse and Addiction Research Programs). The FOA was posted on March 28, 2008, with an original and final closing date listed as May 7, 2011, and an archive date of June 7, 2011, meaning the announcement is no longer active but remains part of the historical record for reference. Applicants or readers needing the complete official announcement were directed to the NIH Grants Guide link, and the NIH Office of Extramural Research (OER) webmaster contact was provided for access or technical issues related to the posting.

Browse more business programs for Drug Abuse Research and Prevention

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education Health

Next opportunity: Epidemiology Of Drug Abuse (R03)

Previous opportunity: Epidemiology Of Drug Abuse (R01)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PA 08 125

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (PA 08 125) also looked into and applied for these:

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PA 08 125", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.